Semaglutide is a drug that belongs to the class of GLP-1 receptor agonists and was originally developed for the treatment of diabetes. In recent years, Ozempic has also been shown to play a promising role in the treatment of obesity. The use of this drug for weight loss is limited to certain indications and requires careful monitoring by a qualified physician.
Mechanisms of action of semaglutide
Semaglutide acts by binding to the GLP-1 receptor and thus induces increased insulin secretion, reduced glucagon release and a delay in gastric emptying. This leads to improved blood glucose control and also contributes to a reduction in appetite and slower food intake. The overall effect on energy metabolism thus favors weight loss.
When can Segamglutide be used?
The indication for the use of semaglutide for weight loss includes adults with a BMI of 30 or higher or a BMI of 27 or higher if at least one weight-related concomitant disease is present. This recommendation is particularly relevant when conventional methods of weight loss do not achieve the desired results.
What do you need to look out for?
The use of semaglutide requires detailed information and monitoring by experienced doctors. The drug is injected subcutaneously on a weekly basis and requires precise application to different areas of the abdomen and thigh to minimize skin irritation. Side effects such as nausea or vomiting should be closely monitored during treatment.
Summary
Semaglutide is a promising option in the treatment of obesity, especially for patients for whom conventional weight loss methods are not sufficiently effective. However, the use of this GLP-1 receptor agonist requires close monitoring by specialist physicians to ensure safe and effective weight loss.
